04 Aug 2009
NIMH Update
Attached is the latest update from NIMH. Note that this Update includes a request for information from the Interagency Autism Coordinating Committee regarding the update of its strategic plan. Please forward to your constituents as appropriate.
We are also pleased to inform you that NIMH has released a couple new publications:
1. Schizophrenia: This booklet on schizophrenia has been revised and the new print version is now available for ordering. (Pub No NIH 09-3517, monthly ordering limit 100)
2. Schizophrenia (easy to read): This new trifold is an easy-to-read publication on the disorder. (Pub No TR 09-3517, monthly ordering limit: 150) Also online at: http://www.nimh.nih.gov/health/publications/schizophrenia-easy-to-read/schizophrenia-easy-to-read.shtml
3. Treatment of Children with Mental Disorders: This guide answers to frequently asked questions about the treatment of mental disorders in children. (Pub No NIH 09-4702, monthly ordering limit 150) Also online at: http://www.nimh.nih.gov/health/publications/treatment-of-children-with-mental-disorders/index.shtml
………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….
Clinical Trial Participation Update
Find Clinical Trials by State:
Bipolar Disorder Genetics: A Collaborative Study
If you have been diagnosed with bipolar disorder (BP) you may be eligible to participate in a research study at the NIH clinical Center. The purpose of this study is to identify genes that may contribute to the development of bipolar disorder (manic depression), and related conditions. Bipolar disorder is a common and potentially life-threatening mood disorder. The tendency to develop bipolar disorder can be inherited, but this is poorly understood and probably involves multiple genes. This study will use genetic markers to map and identify genes that contribute to bipolar disorder. Families and individuals who have the disorder are asked to contribute personal information and a blood sample to an anonymous national database. This information will aid scientists around the world who are working together to develop better treatments for this serious mood disorder. To find out if you qualify or for more information, please call 1-866-644-4363 or email us at kazubad@mail.nih.gov.
For more NIMH Clinical Research Information: http://patientinfo.nimh.nih.gov
